Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Delivery of Exogenous Mir-124 to Glioblastoma Multiform Cells by Wharton’S Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity Publisher Pubmed



Sharif S1 ; Ghahremani MH1, 2 ; Soleimani M3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Toxicology & Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Haematology, Tarbiat Modares University, Tehran, Iran

Source: Stem Cell Reviews and Reports Published:2018


Abstract

MicroRNAs (miRs) are potential therapeutic targets in glioblastoma multiforme (GBM), but the difficulties associated with their delivery to tumor target cells have hampered their widespread use. Mesenchymal stem cells (MSCs) can migrate to the sites of cancers, including GBM and exert anti-tumor effects. In this study, it is shown that Wharton’s jelly-MSCs (WJ-MSCs) have the ability to deliver exogenous miRs to GBM cells and the functional impact of this delivery is characterized. It is found that the labeled miR-124, as an example for miR of interest, can be successfully delivered with WJ-MSCs to U87 GBM cells via dependent or exosome-independent processes. It is demonstrated that the delivered exogenous miR-124 significantly decreases the luciferase activity of the target gene CDK6. In addition, the delivered miR-124 enhances the chemosensitivity of GBM cells to temozolomide and decreases the migration of GBM cells. These results suggest that the use of exogenous miRNA delivery with the derived exosomes from WJ-MSCs may provide a novel approach for miRNA replacement therapy in GBM cancers. © 2017, Springer Science+Business Media, LLC, part of Springer Nature.
Related Docs
View other Related Docs
1. Effects of Human Placenta-Derived Mesenchymal Stem Cells With Nk4 Gene Expression on Glioblastoma Multiforme Cell Lines, Journal of Cellular Biochemistry (2020)
2. Effect of Mesenchymal Stem Cells-Derived Exosomes on Tumor Microenvironment: Tumor Progression Versus Tumor Suppression, Journal of Cellular Physiology (2019)
3. The Significant Role of Micrornas in Gliomas Angiogenesis: A Particular Focus on Molecular Mechanisms and Opportunities for Clinical Application, Cellular and Molecular Neurobiology (2023)
4. Nanotechnology and Bioengineering Approaches to Improve the Potency of Mesenchymal Stem Cell As an Off-The-Shelf Versatile Tumor Delivery Vehicle, Medicinal Research Reviews (2024)
5. The Extracellular Vesicles-Derived From Mesenchymal Stromal Cells: A New Therapeutic Option in Regenerative Medicine, Journal of Cellular Biochemistry (2018)
6. Microrna-4731-5P Delivered by Ad-Mesenchymal Stem Cells Induces Cell Cycle Arrest and Apoptosis in Glioblastoma, Journal of Cellular Physiology (2020)
7. Exosomal Micrornas Derived From Mesenchymal Stem Cells: Cell-To-Cell Messages, Cell Communication and Signaling (2020)
8. Mesenchymal Stem Cells: Rising Concerns Over Their Application in Treatment of Type One Diabetes Mellitus, Journal of Diabetes Research (2015)
Experts (# of related papers)
View all Related Experts
Hamid Reza Mirzaei (5)
Javad Verdi (3)
Other Related Docs
9. Recent Advancements to Engineer Mesenchymal Stem Cells and Their Extracellular Vesicles for Targeting and Destroying Tumors, Progress in Biophysics and Molecular Biology (2023)
10. Current Understanding of the Exosomes and Their Associated Biomolecules in the Glioblastoma Biology, Clinical Treatment, and Diagnosis, Journal of Neuroimmune Pharmacology (2025)
11. Mesenchymal Stem Cell Exosomes: A Two-Edged Sword in Cancer Therapy, International Journal of Nanomedicine (2019)
12. Bone Tissue Engineering Using Human Cells: A Comprehensive Review on Recent Trends, Current Prospects, and Recommendations, Applied Sciences (Switzerland) (2019)
13. Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy, Frontiers in Cell and Developmental Biology (2021)
14. Non-Coding Rnas Enhance the Apoptosis Efficacy of Therapeutic Agents Used for the Treatment of Glioblastoma Multiform, Journal of Drug Targeting (2022)
15. Biological Aspects and Clinical Applications of Mesenchymal Stem Cells: Key Features You Need to Be Aware Of, Current Pharmaceutical Biotechnology (2021)
16. Mesenchymal Stem Cells: A New Platform for Targeting Suicide Genes in Cancer, Journal of Cellular Physiology (2018)
17. Prospects for Manipulation of Mesenchymal Stem Cells in Tumor Therapy: Anti-Angiogenesis Property on the Spotlight, International Journal of Stem Cells (2021)
18. Non-Coding Rnas and Glioma: Focus on Cancer Stem Cells, Molecular Therapy Oncolytics (2022)
19. Genetically Engineered Mesenchymal Stem Cells: Targeted Delivery of Immunomodulatory Agents for Tumor Eradication, Cancer Gene Therapy (2020)
20. Glioblastoma: Exosome and Microrna As Novel Diagnosis Biomarkers, Cancer Gene Therapy (2016)
21. Recent Advances in Mesenchymal Stem Cell Therapy for Multiple Sclerosis: Clinical Applications and Challenges, Frontiers in Cell and Developmental Biology (2025)
22. Exosomal Micrornas and Long Noncoding Rnas: Novel Mediators of Drug Resistance in Lung Cancer, Journal of Cellular Physiology (2022)
23. Exosomes Derived From Mir-34A-Overexpressing Mesenchymal Stem Cells Inhibit in Vitro Tumor Growth: A New Approach for Drug Delivery, Life Sciences (2021)
24. Genetically-Modified Stem Cell in Regenerative Medicine and Cancer Therapy; a New Era, Current Gene Therapy (2022)
25. Mir-153 As a Tumor Suppressor in Glioblastoma Multiforme Is Downregulated by Dna Methylation, Clinical Laboratory (2016)
26. Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale?, Journal of Cellular Physiology (2017)
27. The Relationship Between Molecular Content of Mesenchymal Stem Cells Derived Exosomes and Their Potentials: Opening the Way for Exosomes Based Therapeutics, Biochimie (2019)
28. Microrna: Relevance to Stroke Diagnosis, Prognosis, and Therapy, Journal of Cellular Physiology (2018)
29. Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents, Current Medicinal Chemistry (2016)
30. The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy Via the Modulation of Inflammatory Milieu, Journal of Clinical Medicine (2019)
31. Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications, Current Medicinal Chemistry (2021)
32. Promotion of Cell-Based Therapy: Special Focus on the Cooperation of Mesenchymal Stem Cell Therapy and Gene Therapy for Clinical Trial Studies, Advances in Experimental Medicine and Biology (2018)
33. Camp-Epac Pathway Stimulation Modulate Connexin-43 and Microrna-21 Expression in Glioma Cells, Basic and Clinical Neuroscience (2015)
34. The Potential Use of Mesenchymal Stem Cells-Derived Exosomes As Micrornas Delivery Systems in Different Diseases, Cell Communication and Signaling (2023)
35. Paracrine Effects of Mesenchymal Stem Cells in Ischemic Stroke: Opportunities and Challenges, Molecular Neurobiology (2022)
36. Exosomes As Novel Tools for Renal Cell Carcinoma Therapy, Diagnosis, and Prognosis, Heliyon (2024)
37. Current Advances in Stem Cell Therapy in the Treatment of Multiple Sclerosis, Reviews in the Neurosciences (2023)
38. Differentiation Induction and Proliferation Inhibition by a Cell-Free Approach for Delivery of Exogenous Mirnas to Neuroblastoma Cells Using Mesenchymal Stem Cells, Cell Journal (2021)
39. Topological Analysis of Regulatory Networks Reveals Functionally Key Genes and Mirnas Involved in the Differentiation of Mesenchymal Stem Cells, Iranian Journal of Biotechnology (2021)